Clinical Trial Update: Study Evaluating the Equivalence of GDC-229 and Metronidazole Vaginal Gel 0.75% in the Treatment of Bacterial Vaginosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating equivalence of GDC-229 to Metronidazole vaginal gel for bacterial vaginosis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• GDC-229
• METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: Balmoral Medical company | Conditions: Bacterial Vaginosis | Phase 3 | Status: COMPLETED | Results posted: 2019-10-14